ExploreWatchlistsPricing
  1. JP-listed companies
  2. Momotaro-Gene Inc.
  3. Financials
  4. Provision for income taxes

Momotaro-Gene Inc. (E33052)

Market cap
P/E ratio
Momotaro Genen develops innovative gene therapy drugs using the REIC cancer suppressor gene discovered at Okayama University to selectively kill cancer cells.
SummaryFinancialsDividendsHistoryWorkforce
Period EndProvision for income taxes (Million JPY)YoY (%)
Mar 31, 20231+0.00%
Mar 31, 20221+0.00%
Mar 31, 20211-0.10%
Mar 31, 20201+0.00%
Mar 31, 20191+0.00%
Mar 31, 20181+0.00%
Mar 31, 20171-63.52%
Mar 31, 20163+108.48%
Mar 31, 20151+8.80%
Mar 31, 20141-0.92%
Mar 31, 20131+6.23%
Mar 31, 20121+3.60%
Mar 31, 20111+27.08%
Mar 31, 20101+173.40%
Mar 31, 20090

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat